vs

Side-by-side financial comparison of GEN Restaurant Group, Inc. (GENK) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $49.7M, roughly 1.5× GEN Restaurant Group, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -9.0%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-5.6M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -1.0%).

Gen Korean BBQ is an American chain of all-you-can-eat Korean barbecue restaurants mainly concentrated around the Western U.S. It opened in 2011, and has since grown to 43 locations as of 2024.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

GENK vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.5× larger
PBYI
$75.5M
$49.7M
GENK
Growing faster (revenue YoY)
PBYI
PBYI
+36.7% gap
PBYI
27.7%
-9.0%
GENK
More free cash flow
PBYI
PBYI
$20.0M more FCF
PBYI
$14.4M
$-5.6M
GENK
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-1.0%
GENK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENK
GENK
PBYI
PBYI
Revenue
$49.7M
$75.5M
Net Profit
$-1.9M
Gross Margin
69.3%
Operating Margin
-24.5%
22.7%
Net Margin
-3.8%
Revenue YoY
-9.0%
27.7%
Net Profit YoY
-821.4%
EPS (diluted)
$-0.37
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENK
GENK
PBYI
PBYI
Q4 25
$49.7M
$75.5M
Q3 25
$50.4M
$54.5M
Q2 25
$55.0M
$52.4M
Q1 25
$57.3M
$46.0M
Q4 24
$54.7M
$59.1M
Q3 24
$49.1M
$80.5M
Q2 24
$53.9M
$47.1M
Q1 24
$50.8M
$43.8M
Net Profit
GENK
GENK
PBYI
PBYI
Q4 25
$-1.9M
Q3 25
$-566.0K
$8.8M
Q2 25
$-261.0K
$5.9M
Q1 25
$-301.0K
$3.0M
Q4 24
$-206.0K
Q3 24
$25.0K
$20.3M
Q2 24
$277.0K
$-4.5M
Q1 24
$496.0K
$-4.8M
Gross Margin
GENK
GENK
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
GENK
GENK
PBYI
PBYI
Q4 25
-24.5%
22.7%
Q3 25
-7.4%
17.6%
Q2 25
-3.4%
12.7%
Q1 25
-3.8%
8.7%
Q4 24
-2.4%
22.6%
Q3 24
0.2%
27.4%
Q2 24
3.0%
-4.6%
Q1 24
0.2%
-5.3%
Net Margin
GENK
GENK
PBYI
PBYI
Q4 25
-3.8%
Q3 25
-1.1%
16.2%
Q2 25
-0.5%
11.2%
Q1 25
-0.5%
6.5%
Q4 24
-0.4%
Q3 24
0.1%
25.2%
Q2 24
0.5%
-9.6%
Q1 24
1.0%
-11.0%
EPS (diluted)
GENK
GENK
PBYI
PBYI
Q4 25
$-0.37
$0.26
Q3 25
$-0.11
$0.17
Q2 25
$-0.05
$0.12
Q1 25
$-0.06
$0.06
Q4 24
$-0.05
$0.40
Q3 24
$0.01
$0.41
Q2 24
$0.06
$-0.09
Q1 24
$0.11
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENK
GENK
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$2.8M
$97.5M
Total DebtLower is stronger
$13.6M
$22.7M
Stockholders' EquityBook value
$26.5M
$130.3M
Total Assets
$259.9M
$216.3M
Debt / EquityLower = less leverage
0.51×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENK
GENK
PBYI
PBYI
Q4 25
$2.8M
$97.5M
Q3 25
$4.8M
$94.4M
Q2 25
$9.6M
$96.0M
Q1 25
$15.4M
$93.2M
Q4 24
$23.7M
$101.0M
Q3 24
$22.1M
$96.7M
Q2 24
$29.2M
$96.8M
Q1 24
$28.1M
$107.2M
Total Debt
GENK
GENK
PBYI
PBYI
Q4 25
$13.6M
$22.7M
Q3 25
$10.8M
$34.0M
Q2 25
$7.8M
$45.3M
Q1 25
$6.5M
$56.7M
Q4 24
$6.9M
$68.0M
Q3 24
$7.2M
$79.3M
Q2 24
$7.6M
$90.7M
Q1 24
$7.7M
$102.0M
Stockholders' Equity
GENK
GENK
PBYI
PBYI
Q4 25
$26.5M
$130.3M
Q3 25
$38.1M
$115.3M
Q2 25
$41.0M
$104.7M
Q1 25
$42.8M
$97.1M
Q4 24
$44.1M
$92.1M
Q3 24
$46.5M
$71.1M
Q2 24
$45.9M
$48.5M
Q1 24
$40.4M
$51.0M
Total Assets
GENK
GENK
PBYI
PBYI
Q4 25
$259.9M
$216.3M
Q3 25
$245.5M
$202.9M
Q2 25
$246.3M
$194.9M
Q1 25
$232.4M
$196.2M
Q4 24
$240.4M
$213.3M
Q3 24
$225.7M
$220.7M
Q2 24
$218.8M
$205.0M
Q1 24
$214.5M
$214.1M
Debt / Equity
GENK
GENK
PBYI
PBYI
Q4 25
0.51×
0.17×
Q3 25
0.28×
0.30×
Q2 25
0.19×
0.43×
Q1 25
0.15×
0.58×
Q4 24
0.16×
0.74×
Q3 24
0.16×
1.12×
Q2 24
0.17×
1.87×
Q1 24
0.19×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENK
GENK
PBYI
PBYI
Operating Cash FlowLast quarter
$-426.0K
$14.4M
Free Cash FlowOCF − Capex
$-5.6M
$14.4M
FCF MarginFCF / Revenue
-11.3%
19.1%
Capex IntensityCapex / Revenue
10.5%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-24.3M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENK
GENK
PBYI
PBYI
Q4 25
$-426.0K
$14.4M
Q3 25
$-1.6M
$9.7M
Q2 25
$3.3M
$14.1M
Q1 25
$2.2M
$3.6M
Q4 24
$7.3M
$15.6M
Q3 24
$1.4M
$11.0M
Q2 24
$5.6M
$1.0M
Q1 24
$3.5M
$11.2M
Free Cash Flow
GENK
GENK
PBYI
PBYI
Q4 25
$-5.6M
$14.4M
Q3 25
$-7.7M
$9.7M
Q2 25
$-6.3M
$14.1M
Q1 25
$-4.7M
$3.6M
Q4 24
$165.0K
$15.6M
Q3 24
$-6.8M
$11.0M
Q2 24
$1.2M
$1.0M
Q1 24
$-586.0K
FCF Margin
GENK
GENK
PBYI
PBYI
Q4 25
-11.3%
19.1%
Q3 25
-15.3%
17.7%
Q2 25
-11.5%
26.8%
Q1 25
-8.2%
7.7%
Q4 24
0.3%
26.4%
Q3 24
-13.9%
13.7%
Q2 24
2.3%
2.1%
Q1 24
-1.2%
Capex Intensity
GENK
GENK
PBYI
PBYI
Q4 25
10.5%
0.0%
Q3 25
12.0%
0.0%
Q2 25
17.5%
0.0%
Q1 25
11.9%
0.1%
Q4 24
13.1%
0.0%
Q3 24
16.9%
0.0%
Q2 24
8.0%
0.0%
Q1 24
8.1%
0.0%
Cash Conversion
GENK
GENK
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
57.96×
0.54×
Q2 24
20.06×
Q1 24
7.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons